rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTCGACCTAGCGGGAGGGACTACGAGCAGTACTTCGGGCCG	CSASRPSGRDYEQYF	In	VDJ	1	167	0.17784877529286475	1.0	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	0	3	7	1	26	35	54	42	55		TCRBV20-01,TCRBV20-or09_02												CSASRPSGRDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6902A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4	0	3	0	0	4	1	3	0	0	939	167	772	0	0	0.0	0.0	0.0114778932	1.97704422				115	0.0354372151	1.0	0.288604885	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:08	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 911,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 279,treatment:nact,type of chemo:carbo/taxol	0.0	MSKCC- Snyder- P01-01		4.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGACGGTTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	260	0.27689030883919064		41	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	2	7	5	2	9	26	39	44	41	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6902A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4	0	3	0	0	4	1	3	0	0	939	167	772	0	0	0.0	0.0	0.0114778932	1.97704422				115	0.0354372151	1.0	0.288604885	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:08	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 911,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 279,treatment:nact,type of chemo:carbo/taxol	0.0	MSKCC- Snyder- P01-01		4.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTACTCAAGTCCCATTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	271	0.288604898828541		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	10	5	1	16	26	38	42	39	58		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6902A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4	0	3	0	0	4	1	3	0	0	939	167	772	0	0	0.0	0.0	0.0114778932	1.97704422				115	0.0354372151	1.0	0.288604885	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:08	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 911,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 279,treatment:nact,type of chemo:carbo/taxol	0.0	MSKCC- Snyder- P01-01		4.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCAACAGGGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	241	0.2566560170394036		37	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	4	3	0	25	35	-1	38	46													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6902A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				4	0	3	0	0	4	1	3	0	0	939	167	772	0	0	0.0	0.0	0.0114778932	1.97704422				115	0.0354372151	1.0	0.288604885	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:55:08	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 1,overall survival (days):overall survival (days) 911,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 279,treatment:nact,type of chemo:carbo/taxol	0.0	MSKCC- Snyder- P01-01		4.0	
